Uniting in Adversity, Standing Together in Support: Trinomab Donates 330,000 Yuan to Aid Guangxi Flood Relief 2026-07-20

Mobilizing for love, moving forward in unity! On July 16, 2026, Zhuhai Trinomab Pharmaceutical Co., Ltd. (hereafter referred to as "Trinomab") successfully concluded its company-wide charitable donation drive. Overwhelming numbers of employees responded enthusiastically and actively contributed to a charitable fund with total amount of 330,000 RMB. Through this collective act of warmth, the company demonstrated its corporate social responsibility, and the entire amount was specifically allocated via the Guangxi Charity Federation. The funds raised will be dedicated solely to emergency rescue, material supply, and post-disaster reconstruction efforts for the severe floods recently occurred in Guangxi. By delivering tangible public welfare support, Trinomab aims to assist disaster-stricken communities in swiftly restoring normal production and daily life.



In recent days, multiple regions in Guangxi have been struck by severe floods, resulting in urgent disaster conditions and damage to people's livelihoods. Responding immediately to the flood situation, Trinomab urgently launched a company-wide charitable donation initiative. The company opened voluntary donation channels for all employees, calling on colleagues to contribute according to their capabilities. This effort united the entire workforce to provide targeted assistance to the flood-affected areas of Guangxi, putting the pharmaceutical enterprise's social responsibility into practice through concrete actions and supporting disaster relief and recovery efforts.


图片2.png

Disclaimer


1.Trinomab does not recommend any drugs that have not been approved for marketing or any unapproved indications for use.

2.The medical information in this press release is for informational popularization and news reporting purposes only. It does not constitute medical advertising, nor does it constitute any form of diagnostic or treatment advice, medication guidance, or doctor-patient communication. No individual or institution shall use it for commercial promotion or medical decision-making.


Forward-Looking Statements

The information contained in this press release is as of the date of release. The information released in this press release may contain certain forward-looking statements. These statements are inherently subject to significant risks and uncertainties. When using words such as "expect," "believe," "predict," "anticipate," "intend," and other similar expressions in connection with the company, the purpose is to identify them as forward-looking statements. The company is under no obligation to update these forward-looking statements, regardless of the emergence of new information, future events, or new developments.